Mixed large cell neuroendocrine carcinoma and mucosa-associated lymphoid tissue lymphoma of the lung: A case report

Matsumoto,Takeshi; Imai,Yukihiro; Kosaka,Yasuhiro; Shintani,Takashi; Tomii,Keisuke

doi:10.3892/ol.2015.2994

Mixed large cell neuroendocrine carcinoma and mucosa-associated lymphoid tissue lymphoma of the lung: A case report

Authors:
- Takeshi Matsumoto
- Yukihiro Imai
- Yasuhiro Kosaka
- Takashi Shintani
- Keisuke Tomii
View Affiliations

Affiliations: Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo 650‑0047, Japan, Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo 650‑0047, Japan, Department of Radiation Therapy, Kobe City Medical Center General Hospital, Kobe, Hyogo 650‑0047, Japan
Published online on: February 27, 2015 https://doi.org/10.3892/ol.2015.2994
Pages: 2068-2072
Copyright: © Matsumoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, a 79‑year‑old male was referred to Kobe City Medical Center General Hospital due to an abnormal shadow that was revealed on a chest X‑ray. The patient possessed a five‑year history of consolidation in the right lower lobe, which was diagnosed as chronic aspiration pneumonia and followed up. However, the abnormal shadow adjacent to the pleura gradually increased in size and a novel mass appeared in the right lower lobe that rapidly increased in size. A repeat biopsy revealed a combination of large cell neuroendocrine carcinoma with a clinical tumor‑node‑metastasis (cTNM) stage of cT2bN2M0 (stage 3A) and mucosa‑associated lymphoid tissue lymphoma at Ann Arbor stage 1E. Chemoradiotherapy markedly affected the lesion and the size of the mass was significantly reduced subsequent to four cycles of chemotherapy, which was considered to be a near complete response. The present study reports an extremely rare combination of tumors. The disease course was followed over a period of six years, which included the onset of disease, and the present case may therefore be valuable in clarifying the mechanism of lung cancer development.

View Figures

View References

1	Isaacson P and Wright DH: Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 52:1410–1416. 1983. View Article : Google Scholar : PubMed/NCBI
2	Du MQ: MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop. 47:31–42. 2007. View Article : Google Scholar : PubMed/NCBI
3	Chilosi M, Zinzani PL and Poletti V: Lymphoproliferative lung disorders. Semin Respir Crit Care Med. 26:490–501. 2005. View Article : Google Scholar : PubMed/NCBI
4	Cadranel J, Wislez M and Antoine M: Primary pulmonary lymphoma. Eur Respir J. 20:750–762. 2002. View Article : Google Scholar : PubMed/NCBI
5	Addis BJ, Hyjek E and Isaacson PG: Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia. Histopathology. 13:1–17. 1988. View Article : Google Scholar : PubMed/NCBI
6	Troch M, Streubel B, Petkov V, Turetschek K, Chott A and Raderer M: Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res. 27:3633–3637. 2007.PubMed/NCBI
7	Travis WD, Linnoila RI, Tsokos MG, et al: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol. 15:529–553. 1991. View Article : Google Scholar : PubMed/NCBI
8	Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Fujisawa T and Ohwada H: Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer. 91:1992–2000. 2001. View Article : Google Scholar : PubMed/NCBI
9	Iyoda A, Hiroshima K, Nakatani Y and Fujisawa T: Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma. Ann Thorac Surg. 84:702–707. 2007. View Article : Google Scholar : PubMed/NCBI
10	Iyoda A, Hiroshima K, Moriya Y, Sekine Y, Shibuya K, Iizasa T, Nakatani Y and Fujisawa T: Prognostic impact of large cell neuroendocrine hisotology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J Thorac Cardiovasc Surg. 132:312–315. 2006. View Article : Google Scholar : PubMed/NCBI
11	Fujiwara Y, Sekine I, Tsuta K, et al: Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Jpn J Clin Oncol. 37:482–486. 2007. View Article : Google Scholar : PubMed/NCBI
12	Thieblemont C, Bastion Y, Berger F, et al: Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 15:1624–1630. 1997.PubMed/NCBI
13	Stagnaro E, Tumino R, Parodi S, et al: Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev. 13:431–437. 2004.PubMed/NCBI
14	Oh SY, Kim WS, Kim JS, et al: Pulmonary marginal zone B-cell lymphoma of MALT type - what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. Ann Hematol. 89:563–568. 2010. View Article : Google Scholar : PubMed/NCBI
15	Thieblemont C, Berger F, Dumontet C, et al: Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 95:802–806. 2000.PubMed/NCBI
16	Ichihara E, Tabata M, Takigawa N, et al: Synchronous pulmonary MALT lymphoma and pulmonary adenocarcinoma after metachronous gastric MALT lymphoma and gastric adenocarcinoma. J Thorac Oncol. 3:1362–1363. 2008. View Article : Google Scholar : PubMed/NCBI
17	Suzuki T, Akizawa T, Suzuki H, Kitazume K, Omine M and Mitsuya T: Primary tracheal mucosa-associated lymphoid tissue lymphoma accompanying lung cancer. Common tumorigenesis or coincidental coexistence? Jpn J Thorac Cardiovasc Surg. 48:817–819. 2000. View Article : Google Scholar : PubMed/NCBI
18	Itoh T, Kobayashi D, Shiratuchi N, Rensha K and Minami K: Case of overlapping cancers complicated with sarcoidosis. Nihon Kokyuki Gakkai Zasshi. 47:410–414. 2009.(In Japanese). PubMed/NCBI
19	Chanel S, Burke L, Fiche M, et al: Synchronous pulmonary adenocarcinoma and extranodal marginal zone/low-grade B-cell lymphoma of MALT type. Hum Pathol. 32:129–132. 2001. View Article : Google Scholar : PubMed/NCBI
20	Jung CY and Kwon KY: A case of synchronous lung adenocarcinoma and extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type. Tuberc Respir Dis (Seoul). 73:61–66. 2012. View Article : Google Scholar : PubMed/NCBI
21	Adrish M, Venkatram S, Niazi M and Diaz-Fuentes G: Concurrent lung squamous cell carcinoma and extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type. J Bronchology Interv Pulmonol. 21:96–99. 2014. View Article : Google Scholar : PubMed/NCBI
22	Tihan T and Filippa DA: Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence? Cancer. 77:2325–2331. 1996. View Article : Google Scholar : PubMed/NCBI